GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Evolent Health Inc (STU:9EH) » Definitions » Asset Turnover

Evolent Health (STU:9EH) Asset Turnover : 0.24 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Evolent Health Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Evolent Health's Revenue for the three months ended in Mar. 2024 was €588 Mil. Evolent Health's Total Assets for the quarter that ended in Mar. 2024 was €2,445 Mil. Therefore, Evolent Health's Asset Turnover for the quarter that ended in Mar. 2024 was 0.24.

Asset Turnover is linked to ROE % through Du Pont Formula. Evolent Health's annualized ROE % for the quarter that ended in Mar. 2024 was -6.55%. It is also linked to ROA % through Du Pont Formula. Evolent Health's annualized ROA % for the quarter that ended in Mar. 2024 was -2.60%.


Evolent Health Asset Turnover Historical Data

The historical data trend for Evolent Health's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evolent Health Asset Turnover Chart

Evolent Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.43 0.61 0.67 0.86 0.86

Evolent Health Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 0.18 0.19 0.21 0.24

Competitive Comparison of Evolent Health's Asset Turnover

For the Health Information Services subindustry, Evolent Health's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evolent Health's Asset Turnover Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Evolent Health's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Evolent Health's Asset Turnover falls into.



Evolent Health Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Evolent Health's Asset Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=1800.893/( (1715.525+2457.842)/ 2 )
=1800.893/2086.6835
=0.86

Evolent Health's Asset Turnover for the quarter that ended in Mar. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=588.481/( (2457.842+2432.179)/ 2 )
=588.481/2445.0105
=0.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Evolent Health  (STU:9EH) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Evolent Health's annulized ROE % for the quarter that ended in Mar. 2024 is

ROE %**(Q: Mar. 2024 )
=Net Income/Total Stockholders Equity
=-63.592/971.5915
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-63.592 / 2353.924)*(2353.924 / 2445.0105)*(2445.0105/ 971.5915)
=Net Margin %*Asset Turnover*Equity Multiplier
=-2.7 %*0.9627*2.5165
=ROA %*Equity Multiplier
=-2.60 %*2.5165
=-6.55 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) net income data. The Revenue data used here is four times the quarterly (Mar. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Evolent Health's annulized ROA % for the quarter that ended in Mar. 2024 is

ROA %(Q: Mar. 2024 )
=Net Income/Total Assets
=-63.592/2445.0105
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-63.592 / 2353.924)*(2353.924 / 2445.0105)
=Net Margin %*Asset Turnover
=-2.7 %*0.9627
=-2.60 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) net income data. The Revenue data used here is four times the quarterly (Mar. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Evolent Health Asset Turnover Related Terms

Thank you for viewing the detailed overview of Evolent Health's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Evolent Health (STU:9EH) Business Description

Traded in Other Exchanges
Address
800 N. Glebe Road, Suite 500, Arlington, VA, USA, 22203
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. The company's two reportable segments: EHS and Clinical Solutions. The Company's EHS segment provides an integrated administrative and clinical platform for health plan administration and value-based business infrastructure and clinical Solutions segment addresses a broad spectrum of clinical needs, with tailored solutions for specialty care management in oncology and cardiology and increasingly the musculoskeletal markets and holistic total cost of care improvement. It generates a majority of its revenue from Clinical Solutions segment.

Evolent Health (STU:9EH) Headlines

No Headlines